Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
ACMG Comments to CMS Concerning CLFS Gapfill Preliminary Determinations for GS Codes 81425, 81426, and 81427
-
ACMG Comments to CMS on Proposed NCD for Coverage of NGS for Medicare Beneficiaries with Advanced Cancer (CAG-00450N)
-
Group Sign-on Letter to Congress Supporting the Local Coverage Determination Clarification Act of 2017
-
Group Sign-on Letter to Congress Opposing the Preserving Employee Wellness Programs Act (HR 1313)
-
ACMG Comments to EEOC Concerning Proposed Rule Related to the Genetic Information Nondiscrimination Act (GINA)
-
ACMG Comments to OHRP Concerning Proposed Revisions to the Common Rule
-
ACMG Comments to EEOC Concerning Regulations Under the Americans with Disabilities Act (ADA)
-
Joint Comments to CMS Concerning MolDx Program, Medicare Coverage, and Impact on MoPath Gapfill Determinations
-
ACMG Letter to Palmetto GBA Requesting Reconsideration of Cytogenetic Microarray Coverage
-
ACMG Applauds Supreme Court Decision on Gene Patents